查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614237

馬醫療保健市場：按產品、應用和最終用戶 - 2025-2030 年全球預測

Equine Healthcare Market by Product (Diagnostics tools, Feed Supplements, Pharmaceuticals), Application (Diagnosis, Monitoring & Therapy, Surgical Application), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年馬醫療保健市場規模為32.5億美元，預計2024年將達到34.6億美元，複合年成長率為6.52%，預計到2030年將達到50.7億美元。

馬匹醫療保健市場涵蓋廣泛，專注於透過各種服務和產品來維持馬匹的健康和福祉，包括治療、獸醫護理、營養食品和藥物。對馬醫療保健的需求源於馬在運動、休閒、農業和陪伴方面提供的經濟和情感價值，強調了保持最佳健康和表現的需要。該市場的應用包括疾病預防、損傷治療、生殖健康、診斷和客製化營養計劃。最終用途包括獸醫診所、牧場、賽馬訓練師、繁殖中心等。市場成長受到全球馬匹數量不斷增加、獸醫技術進步、馬術運動日益普及以及飼主對動物福利意識提升不斷提高的影響。該市場正在見證遠端醫療和穿戴式技術等數位健康解決方案提供即時健康監測和資料分析的機會激增。為了抓住這些，相關人員必須投資於物聯網和人工智慧技術的整合，以創新診斷工具和個人化治療計劃。然而，先進治療的高成本、缺乏熟練的獸醫、各種法規以及發展中地區的經濟限制等挑戰構成了主要障礙。另一個限制是與其他畜牧業相比，市場佔有率相對較小。公司應該專注於遺傳疾病預防、損傷幹細胞治療以及有望獲得更好效果的替代藥物等研究領域。與高科技公司合作開發負擔得起的獸醫遠端醫療解決方案也可以推動成長。總體而言，在寵物人性化和運動投資增加的推動下，馬匹醫療保健市場正在不斷發展，但受到成本和可及性問題的阻礙。策略夥伴關係、平價醫療解決方案的持續創新以及在新興市場的有針對性的推廣可以成為該領域顯著成長和進步的催化劑。

主要市場統計
基準年[2023] 32.5億美元
預計年份 [2024] 34.6億美元
預測年份 [2030] 50.7億美元
複合年成長率（%） 6.52%

市場動態：揭示快速發展的馬醫療保健市場的關鍵市場洞察

馬保健市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 馬術運動日益普及，馬匹用於休閒和陪伴的人數不斷增加
    • 人們對動物健康和福利的認知不斷增強
    • 政府和公共部門對馬匹保健的財政支持
  • 市場限制因素
    • 獸醫服務和先進治療的成本上升
  • 市場機會
    • 馬科疾病診斷與治療方法的技術進步
    • 對環保和永續醫療保健產品的需求不斷成長
  • 市場挑戰
    • 副作用和抗藥性細菌的風險

波特五力：駕馭馬醫療保健市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解馬保健市場的外部影響

外部宏觀環境因素在塑造馬保健市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解馬保健市場的競爭格局

對馬醫療保健市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣馬醫療保健市場供應商的績效評估

FPNV 定位矩陣是評估馬醫療保健市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，為馬保健市場的成功指明道路

對於旨在加強其在全球市場的影響力的公司來說，對馬醫療保健市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 馬術運動日益普及，為了娛樂和陪伴而擁有馬匹的人數不斷增加
      • 人們對動物健康和福利的認知不斷增強
      • 政府和公共部門對馬匹保健的財政支持
    • 抑制因素
      • 獸醫服務和先進治療費用高昂
    • 機會
      • 馬科疾病診斷與治療方法的技術進步
      • 對環保和永續醫療保健產品的需求不斷成長
    • 任務
      • 藥物不良反應和抗藥性的風險
  • 市場區隔分析
    • 產品：廣泛使用診斷工具來檢測和管理馬匹疾病
    • 應用：擴大馬匹醫療保健在診斷、監測和治療的應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章馬保健市場：依產品

  • 診斷工具
  • 飼料補充品
    • 關節補充品
    • 維生素和礦物質
  • 藥品
    • 止痛藥
    • 發炎藥
    • 抗生素
    • 驅蟲藥
    • 鎮靜劑
  • 疫苗

第7章馬醫療保健市場：依應用分類

  • 診斷、監測和治療
  • 外科應用

第8章馬醫療保健市場：依最終用戶分類

  • 獸醫診所和醫院
  • 獸醫研究所
  • 獸醫研究組織

第9章美洲馬匹保健市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太馬醫療保健市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的馬保健市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Neogen 宣布與 Terranova 建立生物安全合作夥伴關係
    • Hilltop Bio 推出用於馬關節的 Strydaflex
    • Covetrus 推出智慧免疫蘑菇，支持馬匹強大的免疫防禦
  • 戰略分析和建議

公司名單

  • Alltech Inc.
  • Archer-Daniels-Midland Company
  • Bayer AG
  • Belvoir Equine Limited
  • Boehringer Ingelheim International GmbH
  • Cargill, Incorporated
  • Ceva Sante Animale
  • Covetrus, Inc.
  • Dechra Pharmaceuticals PLC
  • ELANCO ANIMAL HEALTH INCORPORATED
  • ESAOTE SPA
  • Hallmarq Veterinary Imaging Inc.
  • Hilltop Biosciences
  • IDEXX Laboratories, Inc.
  • Kent Nutrition Group
  • Land O'Lakes, Inc.
  • Merck & Co., Inc.
  • Mg Biologics
  • Neogen Corporation
  • Platinum Performance, Inc.
  • Sanofi SA
  • Vetoquinol SA
  • WF Young, Inc.
  • Zoetis Inc.
Product Code: MRR-3F223D52475E

The Equine Healthcare Market was valued at USD 3.25 billion in 2023, expected to reach USD 3.46 billion in 2024, and is projected to grow at a CAGR of 6.52%, to USD 5.07 billion by 2030.

The equine healthcare market encompasses a broad scope focused on maintaining the health and well-being of horses through various services and products, including medical treatments, veterinary care, nutritional supplements, and pharmaceuticals. The necessity for equine healthcare stems from the economic and sentimental value horses provide in sports, leisure, agriculture, and companionship, emphasizing a need for optimal health and performance maintenance. This market finds applications in disease prevention, injury treatment, reproductive health, diagnostics, and customized nutrition plans. End-use scope includes animal clinics, horse farms, racehorse trainers, and breeding centers. Market growth is influenced by an increasing global equine population, technological advancements in veterinary medicine, a rise in equestrian sports popularity, and enhanced owner awareness about animal welfare. Opportunities in this market are burgeoning with digital health solutions like telemedicine and wearable tech, offering real-time health monitoring and data analytics. To seize these, stakeholders must invest in integrating IoT and AI technologies for innovations in diagnostic tools and personalized treatment plans. However, challenges such as high costs of advanced treatments, lack of skilled veterinarians, varying regulations, and economic constraints in developing regions pose significant barriers. Limitations also arise from the relatively small market share compared to other livestock sectors. Businesses should focus on research areas like genetic disease prevention, stem cell therapy for injuries, and alternative medicines that promise better outcomes. Collaborations with tech companies for developing affordable veterinary telehealth solutions could also drive growth. Overall, the equine healthcare market is evolving, driven by rising pet humanization and sports investments, yet hampered by cost and accessibility issues. Strategic partnerships, continued innovation in affordable care solutions, and targeted outreach in emerging markets can serve as a catalyst for substantial growth and advancement in this field.

KEY MARKET STATISTICS
Base Year [2023] USD 3.25 billion
Estimated Year [2024] USD 3.46 billion
Forecast Year [2030] USD 5.07 billion
CAGR (%) 6.52%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Equine Healthcare Market

The Equine Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing popularity of equine sports and increased horse ownership for leisure and companionship
    • Heightened awareness regarding animal health and welfare
    • Financial support offered by government and public organizations for equine healthcare
  • Market Restraints
    • High cost of veterinary services and advanced treatments
  • Market Opportunities
    • Technological advancements in diagnostic and treatment methods for equine diseases
    • Increasing demand for eco-friendly and sustainable healthcare products
  • Market Challenges
    • Risk of adverse drug reactions and resistance

Porter's Five Forces: A Strategic Tool for Navigating the Equine Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Equine Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Equine Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Equine Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Equine Healthcare Market

A detailed market share analysis in the Equine Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Equine Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Equine Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Equine Healthcare Market

A strategic analysis of the Equine Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Equine Healthcare Market, highlighting leading vendors and their innovative profiles. These include Alltech Inc., Archer-Daniels-Midland Company, Bayer AG, Belvoir Equine Limited, Boehringer Ingelheim International GmbH, Cargill, Incorporated, Ceva Sante Animale, Covetrus, Inc., Dechra Pharmaceuticals PLC, ELANCO ANIMAL HEALTH INCORPORATED, ESAOTE SPA, Hallmarq Veterinary Imaging Inc., Hilltop Biosciences, IDEXX Laboratories, Inc., Kent Nutrition Group, Land O'Lakes, Inc., Merck & Co., Inc., Mg Biologics, Neogen Corporation, Platinum Performance, Inc., Sanofi S.A., Vetoquinol S.A., W.F. Young, Inc., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Equine Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Diagnostics tools, Feed Supplements, Pharmaceuticals, and Vaccines. The Feed Supplements is further studied across Joint Supplements and Vitamins & Minerals. The Pharmaceuticals is further studied across Analgesics, Anti-inflammatory Drugs, Antibiotics, Antiparasitics, and Sedatives.
  • Based on Application, market is studied across Diagnosis, Monitoring & Therapy and Surgical Application.
  • Based on End-User, market is studied across Veterinary Clinics & Hospitals, Veterinary Laboratories, and Veterinary Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing popularity of equine sports and increased horse ownership for leisure and companionship
      • 5.1.1.2. Heightened awareness regarding animal health and welfare
      • 5.1.1.3. Financial support offered by government and public organizations for equine healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of veterinary services and advanced treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in diagnostic and treatment methods for equine diseases
      • 5.1.3.2. Increasing demand for eco-friendly and sustainable healthcare products
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of adverse drug reactions and resistance
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Extensive use of diagnostics tools for the detection and management of equine diseases
    • 5.2.2. Application: Increasing adoption of equine healthcare in diagnosis, monitoring & therapy
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Equine Healthcare Market, by Product

  • 6.1. Introduction
  • 6.2. Diagnostics tools
  • 6.3. Feed Supplements
    • 6.3.1. Joint Supplements
    • 6.3.2. Vitamins & Minerals
  • 6.4. Pharmaceuticals
    • 6.4.1. Analgesics
    • 6.4.2. Anti-inflammatory Drugs
    • 6.4.3. Antibiotics
    • 6.4.4. Antiparasitics
    • 6.4.5. Sedatives
  • 6.5. Vaccines

7. Equine Healthcare Market, by Application

  • 7.1. Introduction
  • 7.2. Diagnosis, Monitoring & Therapy
  • 7.3. Surgical Application

8. Equine Healthcare Market, by End-User

  • 8.1. Introduction
  • 8.2. Veterinary Clinics & Hospitals
  • 8.3. Veterinary Laboratories
  • 8.4. Veterinary Research Institutes

9. Americas Equine Healthcare Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Equine Healthcare Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Equine Healthcare Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Neogen Announced Biosecurity Partnership with TerraNova
    • 12.3.2. Hilltop Bio Launched Strydaflex for Equine Joints
    • 12.3.3. Covetrus Launches SmartImmune Mushroom to Help Support Powerful Immune Defense in Horses
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alltech Inc.
  • 2. Archer-Daniels-Midland Company
  • 3. Bayer AG
  • 4. Belvoir Equine Limited
  • 5. Boehringer Ingelheim International GmbH
  • 6. Cargill, Incorporated
  • 7. Ceva Sante Animale
  • 8. Covetrus, Inc.
  • 9. Dechra Pharmaceuticals PLC
  • 10. ELANCO ANIMAL HEALTH INCORPORATED
  • 11. ESAOTE SPA
  • 12. Hallmarq Veterinary Imaging Inc.
  • 13. Hilltop Biosciences
  • 14. IDEXX Laboratories, Inc.
  • 15. Kent Nutrition Group
  • 16. Land O'Lakes, Inc.
  • 17. Merck & Co., Inc.
  • 18. Mg Biologics
  • 19. Neogen Corporation
  • 20. Platinum Performance, Inc.
  • 21. Sanofi S.A.
  • 22. Vetoquinol S.A.
  • 23. W.F. Young, Inc.
  • 24. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. EQUINE HEALTHCARE MARKET RESEARCH PROCESS
  • FIGURE 2. EQUINE HEALTHCARE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EQUINE HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EQUINE HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. EQUINE HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EQUINE HEALTHCARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EQUINE HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EQUINE HEALTHCARE MARKET DYNAMICS
  • TABLE 7. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY DIAGNOSTICS TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY JOINT SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY SEDATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY DIAGNOSIS, MONITORING & THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY SURGICAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VETERINARY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL EQUINE HEALTHCARE MARKET SIZE, BY VETERINARY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES EQUINE HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA EQUINE HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY FEED SUPPLEMENTS, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM EQUINE HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. EQUINE HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. EQUINE HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023